SynthesisOncoimmunology2021

Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

Alberto Carretero-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.